[Form 4] Organon & Co. Insider Trading Activity
Organon & Co. general counsel Kirke Weaver exercised restricted stock units into common shares and had shares withheld for taxes.
Rhea-AI Filing Summary
Organon & Co. general counsel Kirke Weaver exercised restricted stock units into common shares and had shares withheld for taxes. On March 29, 2026, 7,757 restricted stock units converted into 7,757 common shares at a stated price of $0.00 per share. Of these, 2,210 common shares were withheld at $5.84 per share to satisfy tax obligations, a non-market transaction. After these transactions, Weaver directly holds 79,401.163 shares of Organon common stock. The footnotes state each RSU represents one share of common stock and that this RSU award vests in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,757 shares exercised/converted
Exercise
3 txns
Insider
Weaver Kirke
Role
Gen. Counsel & Corp. Secy.
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 7,757 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,757 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,210 | $5.84 | $13K |
Holdings After Transaction:
Restricted Stock Units — 7,757 contracts (Direct);
Common Stock — 79,401.163 shares (Direct)
Footnotes (3)
- F1. This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
- F2. Each RSU represents a contingent right to receive one share of Organon common stock.
- F3. These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Key Figures
RSUs exercised: 7,757 units
Common shares acquired: 7,757 shares
Shares withheld for taxes: 2,210 shares
+3 more
6 metrics
RSUs exercised
7,757 units
Restricted stock units converted into common stock on March 29, 2026
Common shares acquired
7,757 shares
Shares of Organon common stock received from RSU conversion
Shares withheld for taxes
2,210 shares
Tax-withholding disposition at $5.84 per share
Tax-withholding price
$5.84/share
Price used for 2,210 shares delivered for tax liability
Post-transaction holdings
79,401.163 shares
Common stock directly owned after RSU conversion and tax withholding
RSU-to-share ratio
1:1
Each RSU represents one share of Organon common stock
Key Terms
Restricted Stock Units, tax-withholding disposition, Exercise or conversion of derivative security, contingent right, +1 more
5 terms
Restricted Stock Units financial
"This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
contingent right financial
"Each RSU represents a contingent right to receive one share of Organon common stock."
closing market price financial
"This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded."
FAQ
What insider transaction did Organon (OGN) report for Kirke Weaver?
Organon reported that general counsel Kirke Weaver exercised 7,757 restricted stock units into 7,757 common shares. As part of the same event, 2,210 common shares were withheld to cover tax obligations, leaving Weaver with 79,401.163 common shares held directly.
What type of securities did Kirke Weaver exercise in this Organon (OGN) filing?
Kirke Weaver exercised restricted stock units, which are derivative securities. The filing shows 7,757 restricted stock units converting into 7,757 shares of Organon common stock, consistent with the footnote explaining that each RSU represents a contingent right to receive one share of common stock.
How do Kirke Weaver’s Organon (OGN) restricted stock units vest over time?
The restricted stock units referenced in this filing vest in three equal installments. According to the footnotes, they are distributed as Organon common shares on March 29, 2025, March 29, 2026, and March 29, 2027, aligning share delivery with each scheduled vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
